Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Robert Dydo who wrote (376)	2/24/1999 2:55:00 PM
From: Goldberry	Respond to of 572

Hard to know for sure but just maybe we will see a gradual upward growth in share price now especially if they can be progressively in the black in coming quarters. I would think that with the 4th qtr being virtually break even and hopefully 1998 included any write downs anticipated that profits will start to flow. Based on the following Revenue 4th qtr Product sales $ 2,961,641 $ 1,576,054 Cost of sales 1,618,653 1,556,014 Gross margin 1,342,988 20,040 % --- 32% ---- 4% The breakeven point seems to be sales of just over 1.5 million so for every additional $1 mill in sales from here that should provide about .01/per share profit not a lot but once they start to make bottom line more analysts will push the stock. Graham

To: Robert Dydo who wrote (376)	2/26/1999 1:43:00 AM
From: Edward W. Richmond	Read Replies (1) \| Respond to of 572

Robert, I stated that my $1.04 buy order had not been filled. To my surprise I did get a partial fill. So today it closed at $1.02. Oh well, I can't quibble about 2 cents. Also, the bid/ask is 1.05/$1.10. Certainly, in my opinion, this stock is worth $1.04 and considerably more. I am amazed that the price dropped today. I suspect that too many retail investors are looking for an escape after holding this stock for a long time. Regards, Ed